Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata ("AA") and other autoimmune and inflammatory diseases, ...

Adaptive Biotechnologies (“we” or “our”) is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment ...

UCSF has launched the Alzheimer's Tau Platform (ATP) trial, the first large-scale clinical trial testing combination therapies that target both amyloid plaques and tau tangles simultaneously.

A comprehensive review led by Professors Malgorzata Kloc and Xian Chang Li at the Immunobiology and Transplant Science Center ...

They are the most effective marketing deception in modern wellness. But what is really protecting you from infections?

Invertebrate vaccine science has crossed a commercial threshold: Dalan Animal Health’s United States Department of ...

A defense system that cannot distinguish friend from stranger eventually harms the organization it is supposed to protect.

The concept of trained immunity has redefined innate immune responses as adaptable, durable, and context dependent. Natural killer (NK) cells, traditionally ...

Abstract: The integrated sensing and communication-enhanced (ISAC-enhanced) intelligent transportation system (ITS) has great development potential and market value in future urban ...

Highly sensitive next-generation sequencing-based MRD testing will identify eligible patients with T-cell malignancies ...

The experimental SchistoShield vaccine triggered strong B-cell and T-cell immune memory in early U.S. and African clinical trials.

Abstract: The integration of photovoltaic (PV) systems with energy storage systems (ESS) introduces complex design and operational challenges due to the stochastic nature of solar generation and the ...